[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-361939-105":59,"doc-detail-361939-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","upregulation-of-pcat1-pcat2-and-pcat3-lncrnas-in-cervical-cancer-patients-and-their-diagnostic-value","Upregulation of PCAT1, PCAT2, and PCAT3 LncRNAs in cervical cancer patients and their diagnostic value","","Cervical cancer remains one of the most common malignancies among women, and early detection and effective treatment are still limited despite advances in vaccination and screening. Long noncoding RNAs (lncRNAs) are implicated in cancer progression and therapeutic responses. This study evaluates expression patterns of PCAT1, PCAT2, and PCAT3 in cervical cancer to determine their suitability as diagnostic markers and potential therapeutic targets.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/upregulation-of-pcat1-pcat2-and-pcat3-lncrnas-in-cervical-cancer-patients-and-their-diagnostic-value/361939/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/upregulation-of-pcat1-pcat2-and-pcat3-lncrnas-in-cervical-cancer-patients-and-their-diagnostic-value/361939.png","ImageObject",300,407,{"name":92,"@type":93},"Aria","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-04","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main purpose of the study on PCAT1, PCAT2, and PCAT3?","Question",{"text":112,"@type":113},"To investigate expression patterns of PCAT1, PCAT2, and PCAT3 in cervical cancer and evaluate their diagnostic value as potential biomarkers and therapeutic targets.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How do PCAT1, PCAT2, and PCAT3 expression levels differ between tumor and non-tumor tissues?",{"text":117,"@type":113},"The expression levels of PCAT1, PCAT2, and PCAT3 are significantly higher in tumor tissues.",{"name":119,"@type":110,"acceptedAnswer":120},"What diagnostic performance was reported for PCAT1?",{"text":121,"@type":113},"ROC analysis showed a moderate diagnostic biomarker value for PCAT1, with AUC 0.79, sensitivity 79%, and specificity 69%.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},361939,1791172099,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":44,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":19,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","Bazmi etal. BMC Research Notes (2025) 18:326 [https://doi.org/10.1186/s13104-025-07401-1](https://doi.org/10.1186/s13104-025-07401-1)  \nBMC Research Notes  \nRESEARCH NOTE Open Access  \nUpregulation of PCAT1, PCAT2, and PCAT3  LncRNAs in cervical cancer patients and their diagnostic value  \nHadi Bazmi 1†, Asma Alizadeh Asghari 1†, Mahya Barzgar Jalal i 1†, Leila Rezvan2, Fateme Panahi Zang Malek3 and Reza Safaralizadeh 1*  \nAbstract  \nObjective Cervical cancer is one of the most common cancers among women. Despite advances in vaccination and screening, barriers to early detection and effective treatment remain. lncRNAs play an important role in cancer progression and therapeutic responses. New lncRNAs such as PCAT1, PCAT2, and PCAT3 have shown oncogenic activities in multiple cancers, but their role in cervical cancer is not understood. This study investigated the expression patterns of PCAT1, PCAT2, and PCAT3 in cervical cancer to evaluate their use as diagnostic markers and therapeutic targets.  \nResults The expression level of PCAT1, PCAT2, and PCAT3 was significantly (P value \u003C 0. 05) higher in tumor tissues. ROC analysis showed a moderate diagnostic biomarker value for PCAT1 (AUC 0 . 79, sensitivity 79%, specificity 69%) . Spearman’s analysis showed a positive correlation between PCAT1-PCAT2 and PCAT1-PCAT3 . PCAT1, PCAT2, and PCAT3 lncRNAs significantly increase in cervical cancerous tissues and may play a role as novel oncogenes. Their use as clinical diagnostic markers requires further studies.  \nKeywords Cervical cancer (CC), Long noncoding RNAs (lncRNAs), PCAT1, PCAT2, PCAT3, Biomarker  \n†Hadi Bazmi, Asma Alizadeh Asghari and Mahya Barzgar Jalal i contributed equally to this work.  \n*Correspondence:  \nReza Safaralizadeh  \n[Safaralizadeh@tabrizu.ac.ir](Safaralizadeh@tabrizu.ac.ir)  \n1Department of Animal Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran  \n2Department of Plants, Cellular and Molecular Biology, Faculty of Natural Sciences, University of Tabriz, Tabriz, Iran  \n3Department of Molecular Genetics, Ahar Branch, Islamic Azad University, Ahar, Iran  \nIntroduction  \nCC remains among the most commonly detected cancers in women worldwide after breast cancer, colorectal cancer, and lung cancer, according to incidence statistics [1–3]. It causes over 500,000 new cases and significant mortality annually worldwide [1–3]. Resources from underdeveloped and developing nations bear the majority of deaths, as this condition affects more than 85% of patients [4]. The main cause of CC is chronic high-risk HPV infection, particularly HPV-16 and HPV- 18, which together contribute to approximately 70% of all global cases [5]. HPV vaccination and screening have not removed barriers to early detection and treatment in low-resource settings [6].  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/l](vecommons.org/l)icenses/by-nc-nd/4.0/.  \nBazmi et al. BMC Research Notes (2025) 18:326 Page 2 of 9  \nCC diagnosis relies on conventional and ","cbCaibzmnTNY87is","https://ap.wps.com/l/cbCaibzmnTNY87is","pdf",1781246,"English","# Abstract\n# Results\n## Diagnostic biomarker assessment\n## Correlation analysis\n# Introduction\n## Epidemiology and HPV-related causes\n## Diagnosis and current screening methods\n## Treatment approaches and need for new strategies","[{\"question\":\"What is the main purpose of the study on PCAT1, PCAT2, and PCAT3?\",\"answer\":\"To investigate expression patterns of PCAT1, PCAT2, and PCAT3 in cervical cancer and evaluate their diagnostic value as potential biomarkers and therapeutic targets.\"},{\"question\":\"How do PCAT1, PCAT2, and PCAT3 expression levels differ between tumor and non-tumor tissues?\",\"answer\":\"The expression levels of PCAT1, PCAT2, and PCAT3 are significantly higher in tumor tissues.\"},{\"question\":\"What diagnostic performance was reported for PCAT1?\",\"answer\":\"ROC analysis showed a moderate diagnostic biomarker value for PCAT1, with AUC 0.79, sensitivity 79%, and specificity 69%.\"}]","Upregulation of PCAT1, PCAT2, and PCAT3 LncRNAs in cervical cancer patients and their diagnostic value | PDF",1790146065,23,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3de21ee7195740adc40b90c3a7157efe.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/388062289f34da27ed2cb88d6c86a4ef.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/73e159d1ab9afbead6191e36e8ded535.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/acf4eef904d622626da87b9b8798c37a.webp",980,1306]